"Heart Valve Prosthesis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material.
| Descriptor ID |
D006350
|
| MeSH Number(s) |
E07.695.310
|
| Concept/Terms |
Heart Valve Prosthesis- Heart Valve Prosthesis
- Heart Valve Prostheses
- Prostheses, Heart Valve
- Valve Prostheses, Heart
- Valve Prosthesis, Heart
- Prosthesis, Heart Valve
- Cardiac Valve Prosthesis
- Cardiac Valve Prostheses
- Prostheses, Cardiac Valve
- Prosthesis, Cardiac Valve
- Valve Prostheses, Cardiac
- Valve Prosthesis, Cardiac
|
Below are MeSH descriptors whose meaning is more general than "Heart Valve Prosthesis".
Below are MeSH descriptors whose meaning is more specific than "Heart Valve Prosthesis".
This graph shows the total number of publications written about "Heart Valve Prosthesis" by people in this website by year, and whether "Heart Valve Prosthesis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 2 | 1 | 3 |
| 1997 | 2 | 2 | 4 |
| 1998 | 2 | 1 | 3 |
| 2000 | 3 | 0 | 3 |
| 2002 | 3 | 0 | 3 |
| 2003 | 2 | 0 | 2 |
| 2004 | 6 | 1 | 7 |
| 2005 | 2 | 0 | 2 |
| 2006 | 3 | 0 | 3 |
| 2007 | 2 | 1 | 3 |
| 2008 | 4 | 1 | 5 |
| 2009 | 3 | 2 | 5 |
| 2010 | 4 | 1 | 5 |
| 2011 | 4 | 0 | 4 |
| 2012 | 2 | 1 | 3 |
| 2013 | 3 | 2 | 5 |
| 2014 | 6 | 1 | 7 |
| 2015 | 4 | 9 | 13 |
| 2016 | 7 | 4 | 11 |
| 2017 | 8 | 2 | 10 |
| 2018 | 8 | 3 | 11 |
| 2019 | 9 | 3 | 12 |
| 2020 | 20 | 2 | 22 |
| 2021 | 10 | 1 | 11 |
| 2022 | 20 | 1 | 21 |
| 2023 | 14 | 1 | 15 |
| 2024 | 12 | 3 | 15 |
To return to the timeline,
click here.
Below are the most recent publications written about "Heart Valve Prosthesis" by people in Profiles.
-
Contemporary Outcomes of TAVR Using a Balloon-Expandable Valve in Patients With Severe Mitral Stenosis: Insights From the Transcatheter Valve Therapies Registry. Circ Cardiovasc Interv. 2024 Dec; 17(12):e014216.
-
Meta-Analysis of Dedicated vs Off-Label Transcatheter Devices for Native Aortic Regurgitation. JACC Cardiovasc Interv. 2025 Jan 13; 18(1):44-57.
-
Three-Year Outcomes Following TAVR in Younger (<75 Years) Low-Surgical-Risk Severe Aortic Stenosis Patients. Circ Cardiovasc Interv. 2024 Nov; 17(11):e014018.
-
Multicenter Pivotal Study of the Alterra Adaptive Prestent for the Treatment of Pulmonary Regurgitation. JACC Cardiovasc Interv. 2024 Oct 14; 17(19):2287-2297.
-
Direct Oral Anticoagulants for Rheumatic?Heart Disease-Associated Atrial Fibrillation Post-Bioprosthetic Mitral Valve Replacement. JACC Clin Electrophysiol. 2024 Dec; 10(12):2701-2710.
-
Feasibility of intentional bioprosthetic valve fracture in the tricuspid position. Catheter Cardiovasc Interv. 2024 Sep; 104(3):523-530.
-
Sutureless Valves, a "Wireless" Option for Patients With Aortic Valve Disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2024 Jul 23; 84(4):382-407.
-
3-Year Outcomes From the Evolut?Low Risk TAVR Bicuspid Study. JACC Cardiovasc Interv. 2024 Jul 22; 17(14):1667-1675.
-
A Guide to Transcatheter Aortic Valve Design and Systematic Planning for a Redo-TAV (TAV-in-TAV) Procedure. JACC Cardiovasc Interv. 2024 Jul 22; 17(14):1631-1651.
-
Assuring Success?: Selecting Patients With Bicuspid Aortic Valves for TAVR. JACC Cardiovasc Interv. 2024 Jul 22; 17(14):1664-1666.